نتائج البحث - "Small cell"

1

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

المؤلفون: Mihaela Aldea, Arianna Marinello, Michael Duruisseaux, Wael Zrafi, Nicole Conci, Giacomo Massa, Giulio Metro, Isabelle Monnet, Patricia Gomez Iranzo, Fabrizio Tabbo, Emilio Bria, Florian Guisier, Damien Vasseur, Colin R. Lindsay, Santiago Ponce-Aix, Sophie Cousin, Fabrizio Citarella, Vincent Fallet, Jose Nicolas Minatta, Anna Eisert, Hortense de Saint Basile, Clarisse Audigier-Valette, Laura Mezquita, Antonio Calles, Giannis Mountzios, Marco Tagliamento, Jordi Remon Masip, Judith Raimbourg, Safae Terrisse, Alessandro Russo, Diego Cortinovis, Philippe Rochigneux, David James Pinato, Alessio Cortellini, Camille Leonce, Anas Gazzah, Maria-Rosa Ghigna, Roberto Ferrara, Filippo Gustavo Dall’Olio, Francesco Passiglia, Vienna Ludovini, Fabrice Barlesi, Enriqueta Felip, David Planchard, Benjamin Besse

المساهمون: Institut Català de la Salut, [Aldea M] Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France. Paris-Saclay University, Kremlin-Bicêtre, France. [Marinello A] Department of Medical Oncology, International Center for Thoracic Cancers (CICT), Gustave Roussy, Villejuif, France. Department of Medical Oncology, Humanitas Research Hospital, Milan, Italy. [Duruisseaux M] Respiratory Department and Early Phase, Louis Pradel Hospital, Hospices Civils de Lyon. Cancer Research Center of Lyon (CRCL). Univ Lyon, Lyon, France. [Zrafi W] Department of Biostatistics and Bioinformatics, Gustave Roussy, Villejuif, France. [Conci N] Department of Medical Oncology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) University Hospital of Bologna, Bologna, Italy. [Massa G] Department of Medical Oncology, National Cancer Institut, Milan, Italy. [Gomez Iranzo P, Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Otros calificadores::Otros calificadores::/genética [Otros calificadores], RET inhibitors, Pulmons - Càncer - Aspectes genètics, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], chemotherapy, RET fusion, immunotherapy, non-small cell lung cancer, Anomalies cromosòmiques, Oncology, Other subheadings::Other subheadings::/genetics [Other subheadings], aminoácidos, péptidos y proteínas::proteínas::proteínas mutantes::proteínas mutantes quiméricas::proteínas oncogénicas de fusión [COMPUESTOS QUÍMICOS Y DROGAS], Amino Acids, Peptides, and Proteins::Proteins::Mutant Proteins::Mutant Chimeric Proteins::Oncogene Proteins, Fusion [CHEMICALS AND DRUGS]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57f7bd4756ed222514ab170ab21d1c3d
https://doi.org/10.1016/j.jtho.2022.12.018

2

Cardiac Function Modifies the Impact of Heart Base Dose on Survival: A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial

المؤلفون: Matthew Craddock, Ursula Nestle, Jochem Koenig, Tanja Schimek-Jasch, Stephanie Kremp, Stefan Lenz, Kathryn Banfill, Angela Davey, Gareth Price, Ahmed Salem, Corinne Faivre-Finn, Marcel van Herk, Alan McWilliam

المساهمون: Biomedical Engineering and Physics

المصدر: Craddock, M, Nestle, U, Koenig, J, Schimek-Jasch, T, Kremp, S, Lenz, S, Banfill, K, Davey, A, Price, G, Salem, A, Faivre-Finn, C, van Herk, M & McWilliam, A 2023, ' Cardiac Function Modifies the Impact of Heart Base Dose on Survival : A Voxel-Wise Analysis of Patients With Lung Cancer From the PET-Plan Trial ', Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 18, no. 1, pp. 57-66 . https://doi.org/10.1016/j.jtho.2022.09.004
Journal of thoracic oncology, 18(1), 57-66. International Association for the Study of Lung Cancer

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Ejection fraction, Lung Neoplasms, Manchester Cancer Research Centre, ResearchInstitutes_Networks_Beacons/mcrc, Non–small cell, Stroke Volume, Heart, Lung Neoplasms/diagnostic imaging, Cardiac toxicity, Ventricular Function, Left, Oncology, Carcinoma, Non-Small-Cell Lung, Positron-Emission Tomography, Humans, Carcinoma, Non-Small-Cell Lung/diagnostic imaging, Tomography, X-Ray Computed

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6cfb8c41ce36e63b32731c3620a6934
https://doi.org/10.1016/j.jtho.2022.09.004

3

Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study

المؤلفون: Pierre, Mordant, Solenn, Brosseau, Bernard, Milleron, Nicola, Santelmo, Séverine, Fraboulet-Moreau, Benjamin, Besse, Alexandra, Langlais, Dominique, Gossot, Pascal-Alexandre, Thomas, Jean-Louis, Pujol, Charles, Ricordel, Jeannick, Madelaine, Régine, Lamy, Clarisse, Audigier-Valette, Pascale, Missy, Hélène, Blons, Fabrice, Barlesi, Virginie, Westeel

المساهمون: AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut Gustave Roussy (IGR), Département de médecine oncologique [Gustave Roussy], Institut Mutualiste de Montsouris (IMM), Hôpital Arnaud de Villeneuve [CHRU Montpellier], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Oncogenesis, Stress, Signaling (OSS), Université de Rennes (UR)-CRLCC Eugène Marquis (CRLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM), CRLCC Eugène Marquis (CRLCC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS BFC)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), This work was supported by the IFCT. The funding sources had no role in the design, data collection, analysis, or interpretation of the study, or in the preparation of this manuscript

المصدر: Clinical Lung Cancer
Clinical Lung Cancer, 2023, 24 (1), pp.1-10. ⟨10.1016/j.cllc.2022.08.013⟩

مصطلحات موضوعية: Molecular profile, Pulmonary and Respiratory Medicine, Cancer Research, Lung Neoplasms, Stage I-II disease, [SDV.CAN]Life Sciences [q-bio]/Cancer, NSCLC, Prognosis, Small Cell Lung Carcinoma, ErbB Receptors, Oncology, Carcinoma, Non-Small-Cell Lung, Mutation, Humans, Female, Surgery, Prospective Studies, Biomarkers, Neoplasm Staging

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72928c3f4185c9b75cec98c7243b75e3
https://doi.org/10.1016/j.cllc.2022.08.013

View record from ScienceDirect

Full Text via ClinicalKey

4

Salvage Surgery Compared to Surgery After Induction Chemoradiation Therapy for Advanced Lung Cancer

المؤلفون: Shinsuke Uchida, Shun-ichi Watanabe, Yukihiro Yoshida, Kazuo Nakagawa, Keisuke Asakura, Yuko Nakayama, Aki K. Kobayashi, Yuichiro Ohe, Masaya Yotsukura

المصدر: The Annals of Thoracic Surgery. 114:2087-2092

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f497e0cd68db1b549ec45c3e73141922
https://doi.org/10.1016/j.athoracsur.2021.10.036

View record from ScienceDirect

Full Text via ClinicalKey

5

SOX2 como posible biomarcador pronóstico y diana molecular en el cáncer de pulmón: metaanálisis

المؤلفون: K. Zang, Z.-H. Yu, M. Wang, Y. Huang, X.-X. Zhu, B. Yao

المصدر: Revista Clínica Española. 222:584-592

مصطلحات موضوعية: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, SOXB1 Transcription Factors, Humans, General Medicine, Prognosis, Small Cell Lung Carcinoma, Neoplasm Staging, Retrospective Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1f3a2c04235be976fdf3aa0c39eb008
https://doi.org/10.1016/j.rce.2022.05.006

View record from ScienceDirect

6

Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study

المساهمون: Institut Català de la Salut, [Ahn MJ] Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. [Kim HR] Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea. [Yang JCH] Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. [Han JY] Center for Lung Cancer, National Cancer Center, Goyang, South Korea. [Li JY] Department of Clinical Oncology, Hong Kong United Oncology Centre, Kowloon, Hong Kong. [Hochmair MJ] Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria. [Felip E] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Cancer Research, Lung Neoplasms, Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Crizotinib, Asian People, Oncology, Carcinoma, Non-Small-Cell Lung, Asiàtics, Humans, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS], Pulmons - Càncer - Tractament, Protein Kinase Inhibitors

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eccf19458b09903576a48d4f8dd18c37
https://doi.org/10.1016/j.cllc.2022.07.008

View record from ScienceDirect

Full Text via ClinicalKey

7

Efficacy of Brigatinib in Patients With Advanced ALK-Positive NSCLC Who Progressed on Alectinib or Ceritinib: ALK in Lung Cancer Trial of brigAtinib-2 (ALTA-2)

المساهمون: Institut Català de la Salut, [Ou SI] Department of Medicine, Division of Hematology-Oncology, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, California. [Nishio M] Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. [Ahn MJ] Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. [Mok T] State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, People’s Republic of China. [Barlesi F] Aix-Marseille University, CNRS, INSERM, CRCM, Marseille, France. Multidisciplinary Oncology & Therapeutic Innovations Department, Gustave Roussy Cancer Campus, Villejuif, France. [Zhou C] Shanghai Pulmonary Hospital, Shanghai, People’s Republic of China. [Felip E] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Lung Neoplasms, Otros calificadores::/uso terapéutico [Otros calificadores], Carbazoles, Medicaments antineoplàstics - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos [COMPUESTOS QUÍMICOS Y DROGAS], diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Oncology, Carcinoma, Non-Small-Cell Lung, Avaluació de resultats (Assistència sanitària), Humans, Anaplastic Lymphoma Kinase, Other subheadings::/therapeutic use [Other subheadings], Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents [CHEMICALS AND DRUGS], Pulmons - Càncer - Tractament, Protein Kinase Inhibitors